See more : Rajeshwari Cans Limited (RCAN.BO) Income Statement Analysis – Financial Results
Complete financial analysis of 22nd Century Group, Inc. (XXII) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of 22nd Century Group, Inc., a leading company in the Tobacco industry within the Consumer Defensive sector.
You may be interested
- Horizon Minerals Corp. (HZNM) Income Statement Analysis – Financial Results
- United Parcel Service, Inc. (UPS.MX) Income Statement Analysis – Financial Results
- KKR Real Estate Finance Trust Inc. (KREF) Income Statement Analysis – Financial Results
- Jiangsu Lihua Animal Husbandry Co., Ltd. (300761.SZ) Income Statement Analysis – Financial Results
- Kawan Food Berhad (7216.KL) Income Statement Analysis – Financial Results
22nd Century Group, Inc. (XXII)
About 22nd Century Group, Inc.
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32.20M | 62.11M | 30.95M | 28.11M | 25.83M | 26.43M | 16.60M | 12.28M | 8.52M | 528.99K | 7.28M | 18.78K | 1.01M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 40.90M | 60.94M | 28.88M | 26.67M | 25.82M | 25.53M | 17.31M | 12.71M | 9.10M | 498.44K | 461.67K | 67.97K | 418.17K | 2.71K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -8.70M | 1.17M | 2.07M | 1.44M | 14.46K | 898.99K | -707.91K | -429.70K | -580.56K | 30.56K | 6.82M | -49.19K | 593.97K | -2.71K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | -27.00% | 1.89% | 6.69% | 5.12% | 0.06% | 3.40% | -4.26% | -3.50% | -6.81% | 5.78% | 93.66% | -262.01% | 58.68% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 2.64M | 6.56M | 3.27M | 4.13M | 8.06M | 14.99M | 3.37M | 2.34M | 1.67M | 1.25M | 744.23K | 729.23K | 2.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 31.83M | 32.23M | 0.00 | 0.00 | 0.00 | 7.66M | 7.12M | 6.19M | 7.76M | 8.79M | 4.11M | 2.21M | 1.79M | 78.57K | 52.86K | 82.15K | 29.20K | 59.79K |
| Selling & Marketing | 0.00 | 12.29M | 0.00 | 0.00 | 0.00 | 927.41K | 1.16M | 1.58M | 1.36M | 85.93K | 9.05K | 61.88K | 286.03K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 31.83M | 44.52M | 25.88M | 14.97M | 12.96M | 8.59M | 8.28M | 7.78M | 9.12M | 8.88M | 4.12M | 2.27M | 2.07M | 78.57K | 52.86K | 82.15K | 29.20K | 59.79K |
| Other Expenses | 1.76M | 7.20M | 1.25M | 1.35M | 1.43M | 1.34M | 947.00K | 842.18K | 676.29K | 1.64M | 122.02K | 198.41K | 179.95K | 10.73K | 9.94K | 15.53K | 20.29K | 0.00 |
| Operating Expenses | 36.24M | 58.28M | 30.40M | 20.45M | 22.44M | 24.92M | 12.59M | 10.96M | 11.46M | 11.77M | 5.00M | 3.19M | 4.35M | 78.57K | 52.86K | 82.15K | 29.20K | 59.79K |
| Cost & Expenses | 77.14M | 119.22M | 59.28M | 47.12M | 48.26M | 50.44M | 29.90M | 23.67M | 20.57M | 12.27M | 5.47M | 3.26M | 4.77M | 81.28K | 52.86K | 82.15K | 29.20K | 59.79K |
| Interest Income | 219.00K | 313.00K | 321.00K | 1.75M | 1.07M | 1.07M | 115.10K | 16.89K | 31.20K | 30.38K | 0.00 | 0.00 | 0.00 | 1.00 | 15.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 9.37M | 353.00K | 58.00K | 72.00K | 56.38K | 10.94K | 29.10K | 37.75K | 52.98K | 7.09K | 748.61K | 1.49M | 104.00K | 8.66K | 2.62K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 4.86M | 3.59M | 1.54M | 1.53M | 1.64M | 1.34M | 947.00K | 842.18K | 774.31K | 495.30K | 144.29K | 198.41K | 179.95K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -40.41M | -32.89M | -31.00M | -18.07M | -24.86M | -6.61M | -12.05M | -10.70M | -10.20M | -15.13M | -25.38M | -5.04M | -1.06M | -81.28K | -52.86K | -82.15K | -29.20K | -59.79K |
| EBITDA Ratio | -125.49% | -95.81% | -78.25% | -57.50% | -86.53% | -26.92% | -71.64% | -87.39% | -133.00% | -2,144.24% | 28.56% | -16,222.33% | -601.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -44.93M | -57.11M | -28.33M | -19.01M | -22.42M | -24.02M | -13.30M | -11.39M | -12.04M | -11.74M | 1.81M | -3.24M | -3.76M | -81.28K | -52.86K | -82.15K | -29.20K | -59.79K |
| Operating Income Ratio | -139.52% | -91.94% | -91.55% | -67.61% | -86.81% | -90.89% | -80.12% | -92.74% | -141.33% | -2,218.75% | 24.90% | -17,279.09% | -371.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -9.71M | -2.90M | -4.18M | -490.00K | -4.13M | 16.05M | 270.75K | -193.58K | 1.01M | -3.83M | -27.97M | -3.49M | 3.75M | -8.65K | -2.61K | 0.00 | -470.00 | 0.00 |
| Income Before Tax | -54.64M | -60.24M | -32.60M | -19.67M | -26.56M | -7.97M | -13.03M | -11.58M | -11.03M | -15.60M | -26.15M | -6.74M | -1.35M | -89.93K | -55.47K | -82.15K | -29.67K | -59.79K |
| Income Before Tax Ratio | -169.67% | -96.98% | -105.32% | -69.98% | -102.81% | -30.15% | -78.49% | -94.31% | -129.45% | -2,948.13% | -359.33% | -35,881.42% | -133.77% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 47.00K | -434.00K | 14.00K | 38.00K | -2.36M | 15.00M | 375.29K | -164.59K | -42.70K | -94.07K | 870.63K | -1.46K | 1.35M | 89.93K | 55.47K | 82.15K | 29.67K | 59.79K |
| Net Income | -140.78M | -59.80M | -32.61M | -19.71M | -24.20M | -7.97M | -13.03M | -11.58M | -11.03M | -15.60M | -26.15M | -6.74M | -1.35M | -89.93K | -55.47K | -82.15K | -29.67K | -59.79K |
| Net Income Ratio | -437.14% | -96.28% | -105.37% | -70.12% | -93.66% | -30.15% | -78.49% | -94.31% | -129.45% | -2,948.13% | -359.33% | -35,873.67% | -133.77% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -116.47 | -74.43 | -50.40 | -34.08 | -46.13 | -15.38 | -30.91 | -36.00 | -38.85 | -62.40 | -144.00 | -53.20 | -12.33 | -1.24 | -0.77 | -1.15 | -0.82 | -6.09 |
| EPS Diluted | -116.47 | -74.43 | -50.10 | -34.08 | -46.13 | -15.38 | -30.91 | -34.81 | -38.85 | -62.39 | -143.85 | -53.20 | -12.33 | -1.24 | -0.77 | -1.15 | -0.82 | -6.09 |
| Weighted Avg Shares Out | 1.29M | 803.50K | 647.00K | 578.39K | 524.51K | 517.91K | 421.51K | 321.71K | 283.93K | 249.93K | 181.62K | 126.61K | 109.85K | 72.24K | 72.24K | 71.68K | 36.28K | 9.81K |
| Weighted Avg Shares Out (Dil) | 1.29M | 803.50K | 650.87K | 578.39K | 524.51K | 517.91K | 421.51K | 332.68K | 283.93K | 249.97K | 181.81K | 126.61K | 109.85K | 72.24K | 72.24K | 71.68K | 36.28K | 9.81K |
22nd Century Group Reports Third Quarter 2024 Financial Results
Remains on Path to Cash Positive Operations in Q1 2025 Commencing Growth Strategy Leveraging Both Internal and External Brand Assets Across Multiple Categories Mocksville, North Carolina--(Newsfile Corp. - November 12, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco...
22nd Century Group (XXII) to Announce Third Quarter 2024 Results on November 12, 2024
Mocksville, North Carolina--(Newsfile Corp. - November 7, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, will host...
22nd Century Group to Present at the LD Micro Main Event XVII on October 30 in Los Angeles
Mocksville, North Carolina--(Newsfile Corp. - October 21, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that...
22nd Century Regains Compliance with Nasdaq Stockholders' Equity Requirement
Mocksville, North Carolina--(Newsfile Corp. - October 8, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that...
22nd Century Continues CMO Business Expansion with Additional Filtered Cigar Volume
CMO customer adds to previously announced cigarette export business with combined volume significantly adding to profitability Mocksville, North Carolina--(Newsfile Corp. - September 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight...
22nd Century Announces New Branded Products Order with Customer for Southeast Asia
New Customer for 22nd Century's Internally Owned Moonlight Brand Could Increase Factory Volumes by More Than 30% When Fully Scaled, Improve Gross Profit Profile Mocksville, North Carolina--(Newsfile Corp. - September 23, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a...
22nd Century Updates Strategic Growth Initiatives for VLN
Low nicotine tobacco stock on hand can supply up to $85.0 million worth of VLN® revenue and positive cash flow Plans announced for VLN® targeted distribution and expansion to reach over 270,000 retail outlets, expanded international activity, and flanker VLN®...
22nd Century Satisfies IP Licensing and Sponsored Research Obligations to NCSU Through 2025 in an Equity Transaction
Mocksville, North Carolina--(Newsfile Corp. - September 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company leading the fight against nicotine addiction with its FDA authorized 95% less nicotine brand VLN®, today announced an agreement to fund...
22nd Century Group to Participate in the HC Wainwright Conference on September 10, 2024
Mocksville, North Carolina--(Newsfile Corp. - September 6, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company leading the fight against nicotine with its 95% less nicotine brand VLN® focused on nicotine harm reduction and contract manufacturing, today...
22nd Century Raises $1.68 Million in Regulation A Offering, Amends Senior Secured Credit Facility
Mocksville, North Carolina--(Newsfile Corp. - August 28, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced that it has secured an additional $1.68 million in gross proceeds...
Source: https://incomestatements.info
Category: Stock Reports